## Trump Signs Off on Firing FDA Commissioner Marty Makary, Sources Say
President Trump has approved a plan to remove Food and Drug Administration Commissioner Marty Makary from his post, according to reports from The Wall Street Journal, Bloomberg, The Washington Post, and Politico. However, insiders caution that the plan is not final and could still change, leaving Makary's fate uncertain as the administration weighs its next moves.

The reported decision follows a turbulent period at the FDA, marked by internal strife over DOGE-related budget cuts, personnel conflicts, and high-stakes regulatory battles. Makary, a surgeon and health policy researcher appointed during Trump's term, faced mounting pressure over vaccine approvals, gene therapy guidelines, abortion pill oversight, and vape regulation—issues that placed the agency at the center of political and scientific debate. The Washington Post notes that the administration has not yet selected an acting director to replace Makary should he depart.

The potential ouster signals continued upheaval at one of the nation's most critical public health agencies. With the FDA overseeing drug safety, food standards, and medical device approvals, leadership instability could affect regulatory timelines and policy direction across the pharmaceutical and biotechnology sectors. Industry watchers and public health officials will be monitoring closely for confirmation of Makary's exit and any indication of who might step into the acting role, a decision that could shape the agency's trajectory on contentious issues ranging from reproductive health to tobacco control.
---
- **Source**: Ars Technica
- **Sector**: The Network
- **Tags**: FDA, Marty Makary, Trump administration, regulatory shake-up, public health
- **Credibility**: unverified
- **Published**: 2026-05-08 23:54:41
- **ID**: 80844
- **URL**: https://whisperx.ai/en/intel/80844